Showing results (381-390 of 631) with videos related to

Sort By:
Pageof 64
Thrombosis Research|October 15, 1985
Aspirin, indomethacin and dazoxiben do not affect the fibrinolytic activation induced by venous occlusionH Bounameaux, P Gresele, M Hanss, et al.
European Journal of Biochemistry|August 15, 1988
Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1)M C Alessi, P J Declerck, M De Mol, et al.
Acta Clinica Belgica|January 1, 1992
A randomized placebo controlled trial on the effects of simvastatin, a HMG-CoA reductase inhibitor, on blood lipids and fibrinolytic parametersH Jacobs, F Van de Werf, E Lesaffre, et al.
European Heart Journal|August 1, 1987
Treatment of prosthetic tricuspid valve thrombosis with recombinant tissue-type plasminogen activatorP Cambier, P Mombaerts, H De Geest, et al.
Thrombosis and Haemostasis|April 25, 1989
Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbitsP Holvoet, J M Stassen, Y Hashimoto, et al.
Blood|October 9, 1999
Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stressG Theilmeier, T Lenaerts, C Remacle, et al.
European Journal of Biochemistry|August 15, 1994
Characterization of the interaction between plasminogen and staphylokinaseH R Lijnen, F De Cock, B Van Hoef, et al.
Toxicologic Pathology|July 10, 2001
Toxicology studies with recombinant staphylokinase and with SY 161-P5, a polyethylene glycol-derivatized cysteine-substitution mutantL Moons, I Vanlinthout, I Roelants, et al.
Blood|August 15, 2000
Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopesY Laroche, S Heymans, S Capaert, et al.
Thrombosis and Haemostasis|March 28, 2002
Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesityH R Lijnen, Hoef B Van, L Frederix, et al.
Pageof 64